Talaris Therapeutics : Costs Associated with Exit/Disposal - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | April 14, 2023
Source: marketscreener.com
Page 35 - Former Address News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Former Address. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Former Address Today - Breaking & Trending Today
Apollo Global Management : Tenth Supplemental Indenture - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ... | April 14, 2023
Source: marketscreener.com
General Mills : Underwriting Agreement - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ... | April 13, 2023
Source: marketscreener.com
KLDiscovery : Management Compensation - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | April 13, 2023
Source: marketscreener.com
Achison : Changes in Control - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 13, 2023
Source: marketscreener.com